Diclofenac - Novartis

Drug Profile

Diclofenac - Novartis

Alternative Names: Diclofenac potassium soft-gelatin capsules -Novartis

Latest Information Update: 08 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novartis
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Dental pain

Most Recent Events

  • 08 Aug 2017 No recent reports of development identified - Phase-I/II for Dental pain (In volunteers) in India (PO)
  • 08 Aug 2017 No recent reports of development identified - Phase-III for Dental pain in USA (PO)
  • 01 Apr 2015 Phase-III clinical trials in Dental pain in USA (PO) (NCT02476422)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top